Back
Lam Research Vs. Novo Nordisk AS Industry Stock Comparison
Buy
64
LRCX
Lam Research
Last Price:
$78.56
Seasonality Move:
13.28%
Sell
9
NONOF
Novo Nordisk AS
Last Price:
$83.98
Seasonality Move:
8.64%
Buy
64
Lam Research (LRCX)
is a Buy
Is Lam Research a Buy, Sell or Hold?
-
The current Lam Research [LRCX] share price is $77.98. The Score for LRCX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
LRCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
9
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $83.81. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
LRCX Stock Price Chart
What is Lam Research's stock price today?
-
The Lam Research share price today is $77.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LRCX is experiencing slight selling pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $83.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
LRCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 58.71 | Buy |
Chaikin Money Flow: | -5198475 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.99 - 77.59) | Buy |
Bollinger Bands (100): | (72.91 - 81.59) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.26 | Sell |
Relative Strength Index (14 RSI): | 29.14 | Sell |
Chaikin Money Flow: | -11150 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.64 - 110.9) | Sell |
Bollinger Bands (100): | (100.73 - 130.01) | Sell |
LRCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 73.89 | Buy |
20-day SMA: | 74.9 | Buy |
50-day SMA: | 74.91 | Buy |
200-day SMA: | 86.35 | Sell |
8-day EMA: | 74.54 | Buy |
20-day EMA: | 74.52 | Buy |
50-day EMA: | 75.48 | Buy |
200-day EMA: | 80.5 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.44 | Sell |
20-day SMA: | 97.55 | Sell |
50-day SMA: | 103.66 | Sell |
200-day SMA: | 124.08 | Sell |
8-day EMA: | 87.79 | Sell |
20-day EMA: | 94.23 | Sell |
50-day EMA: | 102.94 | Sell |
200-day EMA: | 115.31 | Sell |
Lam Research Earnings Growth & LRCX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $26.21 per share, and an increase next year of $0.62 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Lam Research Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |